DHSC_PCP_HPV Self-sampling Cost Effectiveness Model

The UK NSC is looking to appoint a competent supplier to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK.

This is particularly important given that testing for HPV on a vaginal/urine self-sample could be slightly less sensitive than a clinician taken cervical sample.

Therefore, modelling is required to understand how the self-sampling offer under different uptake scenarios could impact on the number of screen-detected HPV and treated cervical lesion.

Contract Project Reference: C253383 Title: DHSC_PCP_HPV Self-sampling Cost Effectiveness Model Contract term: 18 months with the option to extend for a period of up to 6 months.

Estimated contract value (including extensions): £250,000 excluding VAT (£300,000 including VAT).

The opportunity is available on the D…